Håkan Rosén

Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden.

Saab Ventures is the venture capital unit of Saab AB (ST: SAAB), which was founded in 1937 as Svenska Aeroplan Aktiebolaget to produce military aircraft for Sweden. Grown into a global group, the firm provides products and services for military defense and civil security. Their corporate venture division Saab Ventures was established in 2001 and is based in Linköping, Sweden. Saab Ventures invests from the balance sheet of Saab and focuses on technologies and markets that are relevant to Saab's short- and long-term strategies. They aim to enhance Saab's access to innovative key technologies.

TRACAB is the world leading company in creating real-time digital sports data and in turn converting the data into powerful content products for sports fans. Using patented image processing technology developed by its shareholder SAAB, TRACAB is able to capture all movements in a sports arena in real-time. The captured data is packaged into different media products for different platforms such as broadband, broadcast, print and mobile. It is made available to the consumer both in real-time and in post-production. The technology is well proven and is used by several national football leagues and the UEFA Champions League. It was also used for all matches during the EURO 2008. Since 2004, the TRACAB system has been used in over 1,000 live matches.

Micromuscle AB develops electro-active polymer technology products. It focuses on vascular applications where EAP has considerable potential and enables functionality for medical devices. The company's products are used in medical and life science applications. Micromuscle was founded in 2000 and is headquartered in Linköping, Sweden

Iteksa Venture AB is engaged in developing the companies in its portfolio and making investments in new companies. It invests primarily in high-tech companies in the Linköping region. The company is headquartered in Linköping, Sweden.